Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...
News Medical on MSN11d
New study confirms GLP-1 medications are safe for mental health in diabetesResearchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 ...
The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...
Hosted on MSN11d
GLP-1 Receptor Agonist Use Not Linked to Increased Suicide RiskMONDAY, March 3, 2025 (HealthDay News) -- Glucagon-like peptide-1 (GLP-1 ... new user cohort study to examine whether use of ...
HealthDay on MSN3d
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DMFor patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced ...
Depression risk for patients receiving GLP-1 RA was slightly higher than those receiving SGLT-2i and lower than those receiving DPP-4i.
HealthDay on MSN8d
No Link Seen Between Preop GLP-1 Receptor Agonist Use and Postop Aspiration PneumoniaTHURSDAY, March 6, 2025 (HealthDay News) -- Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is not ...
News-Medical.Net on MSN5d
GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patientsResearchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
ACCP Position Statement: "Ensuring the Appropriate Use of Glucagon-Like Peptide-1 Receptor Agonists"
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback